GSK to acquire Novartis’ stake in consumer healthcare JV for $13bn

This article was originally published here

British drugmaker GlaxoSmithKline (GSK) has agreed to purchase Novartis’ 36.5% stake in its consumer healthcare joint venture (JV) for $13bn.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply